Drugs for cardiovascular disease. Spoilt for choice?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.7, 1997-07, pp. : 915-918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs for Cardiovascular Disease Prevention in Women: Implications of the AHA Guidelines - 2007 Update

By Wenger Nanette K.

Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. : 339-358

Adis International

Access to resources Recommend Favorite

Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease

By Sunder-Plassmann G. Winkelmayer W.C. Födinger M.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2637-2652

Informa Healthcare

Access to resources Recommend Favorite

Oligonucleotide-based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs

Current Drug Targets, Vol. 1, Iss. 1, 2000-07 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Discontinued drugs in 2012: cardiovascular drugs

By Zhao Hong-Ping Jiang Hong-Min Xiang Bing-Ren

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1437-1451

Informa Healthcare

Access to resources Recommend Favorite

Discontinued drugs in 2007: cardiovascular drugs

By Xu-song Zhang Bing-ren Xiang

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1817-1828

Informa Healthcare

Access to resources Recommend Favorite